Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Health and Quality of Life Outcomes|February 2, 2013
Improving valuation sampling of EQ-5D health statesAdrian Bagust
Health Economics|September 24, 2004
Modelling EuroQol health-related utility values for diabetic complications from CODE-2 dataAdrian Bagust, Sophie Beale
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 1, 2013
Survival analysis and extrapolation modeling of time-to-event clinical trial data for economic evaluation: an alternative approachAdrian Bagust, Sophie Beale
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 21, 2018
Exploring the Effects of Early Censoring and Analysis of Clinical Trial Survival Data on Effectiveness and Cost-effectiveness Estimation through a Case Study in Advanced Breast CancerAdrian Bagust, Sophie J Beale
Health Policy (Amsterdam, Netherlands)|December 7, 2002
A model for costs of stroke servicesGun Sundberg, Adrian Bagust, Andreas Terént
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Docetaxel in combination with doxorubicin and cyclophosphamide as adjuvant treatment for early node-positive breast cancer: a cost-effectiveness and cost-utility analysisSorrel E Wolowacz, David A Cameron, Helen C Tate, et al.
Pharmacoeconomics|June 28, 2006
Cost-effectiveness of rosiglitazone combination therapy for the treatment of type 2 diabetes mellitus in the UKSophie Beale, Adrian Bagust, Arran T Shearer, et al.
Pharmacoeconomics|June 28, 2006
Cost-effectiveness of rosiglitazone oral combination for the treatment of type 2 diabetes in GermanyArran T Shearer, Adrian Bagust, Andreas Liebl, et al.
Plos One|February 4, 2010
The average body surface area of adult cancer patients in the UK: a multicentre retrospective studyJoseph J Sacco, Joanne Botten, Fergus Macbeth, et al.
Thorax|February 10, 2015
A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancerGerlinde Pilkington, Angela Boland, Tamara Brown, et al.
Pageof 3